Edan Instruments

Edan Instruments Equity

The The Equity of Edan Instruments (300206.SZ) as of Oct 19, 2026 is 2.19 B CNY. In the previous year, The Equity was 2.01 B CNY — a change of 9.18% (higher).

Equity

2.19 BCNY

YoY

9.18%

Last updated:

In 2025, Edan Instruments's equity was 2.19 B CNY, a 9.18% increase from the 2.01 B CNY equity in the previous year.

The Edan Instruments Equity history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Equity
Date
Equity
Jan 1, 2018
1.25 B CNY
Jan 1, 2019
1.29 B CNY
Jan 1, 2020
1.81 B CNY
Jan 1, 2021
1.73 B CNY
Jan 1, 2022
1.85 B CNY
Jan 1, 2023
1.97 B CNY
Jan 1, 2024
2.01 B CNY
Jan 1, 2025
2.19 B CNY
The Edan Instruments Equity history
YEAREquityYoY
2.19 BCNY+9.18%
2.01 BCNY+2.20%
1.97 BCNY+6.06%
1.85 BCNY+6.93%
1.73 BCNY-4.31%
1.81 BCNY+40.28%
1.29 BCNY+3.63%
1.25 BCNY+0.93%
1.23 BCNY+2.63%
1.20 BCNY+1.40%
1.19 BCNY+2.09%
1.16 BCNY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Edan Instruments Stock analysis

What does Edan Instruments do? Edan Instruments Inc, based in Shenzhen, China, operates in the Health Care sector, specializing in medical equipment design, manufacturing, and R&D. The company employs 2,711 full-time staff and offers products such as fetal heart monitors, electrocardiographs, multi-variable monitors, and ultrasonic diagnostic systems. It also provides spare parts and in vitro diagnostics solutions. Listed on 21 April 2011, Edan serves global markets with its comprehensive medical technology portfolio. Edan Instruments is one of the most popular companies on Eulerpool.

Equity Details

Analyzing Edan Instruments's Equity

Edan Instruments's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Edan Instruments's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Edan Instruments's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Edan Instruments's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Edan Instruments’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Edan Instruments stock

The Equity of Edan Instruments is 2.19 B CNY in 2025.

The Equity of Edan Instruments changed from 2.01 B CNY to 2.19 B CNY, representing a 9.18% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of The Equity Edan Instruments since 2006 – with annual values, charts, and detailed analysis.

The Equity's CNY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track The Equity's Edan Instruments historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Edan Instruments

All Key Metrics — Edan Instruments